Free Trial

Zynex (ZYXI) Competitors

Zynex logo
$1.55 0.00 (0.00%)
Closing price 09/19/2025 04:00 PM Eastern
Extended Trading
$1.54 -0.02 (-0.97%)
As of 09/19/2025 06:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZYXI vs. NYXH, SPAI, LNSR, LAKE, INO, PROF, RCEL, LUCD, HYPR, and PDEX

Should you be buying Zynex stock or one of its competitors? The main competitors of Zynex include Nyxoah (NYXH), Safe Pro Group (SPAI), LENSAR (LNSR), Lakeland Industries (LAKE), Inovio Pharmaceuticals (INO), Profound Medical (PROF), Avita Medical (RCEL), Lucid Diagnostics (LUCD), Hyperfine (HYPR), and Pro-Dex (PDEX). These companies are all part of the "medical equipment" industry.

Zynex vs. Its Competitors

Zynex (NASDAQ:ZYXI) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

Zynex has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zynex$192.35M0.24$2.99M-$0.94-1.65
Nyxoah$4.93M34.11-$64.10M-$2.30-2.15

Zynex has a net margin of -19.79% compared to Nyxoah's net margin of -1,541.84%. Zynex's return on equity of -78.54% beat Nyxoah's return on equity.

Company Net Margins Return on Equity Return on Assets
Zynex-19.79% -78.54% -16.70%
Nyxoah -1,541.84%-79.18%-54.92%

Zynex has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.6, indicating that its stock price is 60% more volatile than the S&P 500.

In the previous week, Nyxoah had 3 more articles in the media than Zynex. MarketBeat recorded 3 mentions for Nyxoah and 0 mentions for Zynex. Zynex's average media sentiment score of 0.00 beat Nyxoah's score of -0.28 indicating that Zynex is being referred to more favorably in the media.

Company Overall Sentiment
Zynex Neutral
Nyxoah Neutral

Zynex presently has a consensus target price of $4.90, suggesting a potential upside of 216.13%. Nyxoah has a consensus target price of $15.00, suggesting a potential upside of 203.64%. Given Zynex's higher probable upside, equities analysts plainly believe Zynex is more favorable than Nyxoah.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zynex
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Nyxoah
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

29.7% of Zynex shares are owned by institutional investors. 49.3% of Zynex shares are owned by company insiders. Comparatively, 17.1% of Nyxoah shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Zynex beats Nyxoah on 11 of the 16 factors compared between the two stocks.

Get Zynex News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZYXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZYXI vs. The Competition

MetricZynexMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$46.96M$10.74B$5.80B$10.40B
Dividend YieldN/A1.88%5.63%4.60%
P/E Ratio-1.6521.6480.5826.78
Price / Sales0.2431.96534.44123.53
Price / Cash6.3524.5037.9961.55
Price / Book1.383.4215.776.40
Net Income$2.99M$210.63M$3.30B$271.80M
7 Day Performance4.73%-0.02%5.36%3.49%
1 Month Performance0.65%1.47%8.10%9.90%
1 Year Performance-80.91%-9.87%81.36%28.62%

Zynex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZYXI
Zynex
1.845 of 5 stars
$1.55
flat
$4.90
+216.1%
-81.4%$46.96M$192.35M-1.65770
NYXH
Nyxoah
2.2553 of 5 stars
$4.77
-9.0%
$15.00
+214.5%
-42.6%$178.48M$4.89M-2.07110High Trading Volume
SPAI
Safe Pro Group
3.3084 of 5 stars
$7.41
-6.8%
$10.50
+41.7%
+137.2%$149.56M$2.17M-9.2611Upcoming Earnings
Analyst Revision
LNSR
LENSAR
1.3947 of 5 stars
$12.34
-1.0%
$15.00
+21.6%
+187.2%$148.83M$53.49M-2.93110Positive News
LAKE
Lakeland Industries
4.8218 of 5 stars
$14.49
-1.0%
$25.00
+72.5%
-26.8%$140.02M$167.21M-5.292,100News Coverage
Analyst Upgrade
Short Interest ↓
Analyst Revision
INO
Inovio Pharmaceuticals
3.4367 of 5 stars
$2.28
-4.2%
$8.80
+286.0%
-65.6%$126.48M$220K-0.87320
PROF
Profound Medical
1.4738 of 5 stars
$4.09
+1.2%
$11.00
+168.9%
-44.6%$121.69M$10.68M-2.80150News Coverage
RCEL
Avita Medical
2.4061 of 5 stars
$6.76
+48.2%
$11.60
+71.6%
-49.5%$121.38M$64.25M-3.43130High Trading Volume
LUCD
Lucid Diagnostics
2.9447 of 5 stars
$1.06
+2.9%
$3.65
+244.3%
+33.1%$111.73M$4.35M-0.8970Analyst Downgrade
Gap Up
HYPR
Hyperfine
0.9682 of 5 stars
$1.39
-2.1%
$1.28
-7.7%
+39.4%$111.58M$12.89M-2.67190
PDEX
Pro-Dex
2.5638 of 5 stars
$32.62
-1.4%
$56.00
+71.7%
+24.4%$107.87M$66.59M12.08140

Related Companies and Tools


This page (NASDAQ:ZYXI) was last updated on 9/20/2025 by MarketBeat.com Staff
From Our Partners